GENB
Generate Biomedicines, Inc. Common Stock
NASDAQ: GENB · HEALTHCARE · BIOTECHNOLOGY
$12.63
+2.02% today
Updated 2026-04-30
Market cap
$1.59B
P/E ratio
—
P/S ratio
49.75x
EPS (TTM)
$-2.18
Dividend yield
—
52W range
$11 – $16
Volume
0.6M
Generate Biomedicines, Inc. Common Stock (GENB) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
-737.00%
ROE
-81.70%
ROA
-34.60%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2024 | $20.46M | $-173.77M | 100.00% | -962.60% | -849.36% |
| 2025 | $31.89M | $-203.15M | 100.00% | -737.04% | -636.99% |